Cohen Capital Management’s Biogen BIIB Stock Holding History

Cohen Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-720	Closed	-$204K	–	149
2021 Q3	$204K	Hold	720	–	–	0.04%	147
2021 Q2	$249K	Hold	720	–	–	0.04%	137
2021 Q1	$201K	Buy	+720	New	+$194K	0.04%	142
2020 Q4	–	Sell	-720	Closed	-$204K	–	145
2020 Q3	$204K	Buy	+720	New	+$201K	0.05%	135
2020 Q2	–	Sell	-720	Closed	-$228K	–	141
2020 Q1	$228K	Buy	720 +60	+9%	+$18.2K	0.07%	117
2019 Q4	$196K	Buy	+660	New	+$183K	0.04%	131
2019 Q1	–	Sell	-660	Closed	-$199K	–	132
2018 Q4	$199K	Buy	660 +60	+10%	+$19.1K	0.06%	123
2018 Q3	$212K	Buy	+600	New	+$207K	0.05%	134
2017 Q2	–	Sell	-650	Closed	-$178K	–	153
2017 Q1	$178K	Buy	+650	New	+$184K	0.05%	129
2016 Q4	–	Sell	-650	Closed	-$203K	–	128
2016 Q3	$203K	Buy	+650	New	+$193K	0.06%	119
2014 Q2	–	Sell	-1,074	Closed	-$329K	–	132
2014 Q1	$329K	Buy	+1,074	New	+$341K	0.09%	111

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cohen Capital Management's BIIB Position: Q4 2021 in Review

Cohen Capital Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 720 shares — an estimated $204K sold.

Cohen Capital Management first reported a position in BIIB in Q1 2014 and held it in 11 quarters. The position peaked at $329K in Q1 2014. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Cohen Capital Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Cohen Capital Management sold 720 Biogen shares in Q4 2021, an estimated $204K.
Cohen Capital Management first reported a position in Biogen in Q1 2014 and held it in 11 quarters.
Cohen Capital Management's Biogen position peaked at $329K in Q1 2014.
1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Cohen Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.